apelin
endogen
peptid
ligand
dreceptor
aplnr
potent
posit
inotrop
activ
vasodilatori
action
apj
g
proteincoupl
receptor
share
signific
homolog
angiotensin
ii
type
receptor
axi
regul
cardiovascular
function
includ
blood
pressur
cardiac
contractil
fluid
balanc
therebi
exert
benefici
effect
cardiovascular
system
treatment
apelin
peptid
vivo
improv
cardiac
contractil
output
myocardi
infarct
rat
normal
mice
protect
heart
pressur
overload
isoproterenolinduc
injuri
ischemia
reperfus
injuri
studi
apelin
knockout
apj
knockout
mice
other
demonstr
endogen
axi
regul
heart
contractil
associ
age
exercis
pressur
overload
absenc
apelin
apj
express
mutant
mice
show
contractil
dysfunct
contrast
apj
identifi
dual
receptor
mediat
cardiac
hypertrophi
via
signal
thu
precis
role
endogen
apelin
signal
heart
function
remain
elus
cardiac
hypertrophi
adapt
respons
maintain
cardiac
function
event
increas
workload
although
prolong
cardiac
hypertrophi
lead
heart
failur
via
ischemia
cardiomyocyt
addit
cardiac
fibrosi
advers
increas
tissu
stiff
impair
ventricular
function
consist
cardiac
hypertrophi
develop
fibrosi
correl
deterior
myocardi
function
heart
failur
thu
cardiac
hypertrophi
fibrosi
key
featur
heart
failur
apelin
inotrop
protect
role
heart
attract
potenti
therapeut
candid
treat
heart
failur
apelin
also
identifi
substrat
angiotensinconvert
enzym
cleav
apelin
similar
effici
primari
substrat
angiotensin
ii
ang
ii
neg
regul
system
ra
inactiv
ang
ii
convert
angiotensin
ang
wherea
angiotensinconvert
enzym
activ
ra
convert
ang
ang
ii
also
identifi
regul
heart
failur
diabet
nephropathi
acut
lung
failur
sar
sever
acut
respiratori
syndrom
coronaviru
receptor
apelinapj
signal
shown
counteract
effect
ang
ii
defin
physiolog
pathophysiolog
set
instanc
hypertens
rat
model
continu
infus
ang
ii
downregul
apelin
apj
express
shown
apelin
upregul
express
apelininduc
downregul
ang
ii
signal
enhanc
ang
receptor
signal
age
fail
heart
hand
suggest
counterbalanc
effect
axi
ang
signal
mediat
receptor
dimer
apj
receptor
physic
interact
receptor
exogen
apelin
neg
regul
ang
signal
vitro
cell
cultur
system
vivo
atherosclerosi
model
howev
whether
endogen
apelin
counteract
overactiv
ra
heart
remain
unexplor
studi
aim
determin
effect
endogen
apelin
ang
iiinduc
patholog
heart
show
ang
iimedi
cardiac
dysfunct
hypertrophi
fibrosi
augment
apelin
knockout
apelin
ko
mice
first
examin
whether
ang
ii
level
affect
apelin
ko
mice
subject
plasma
analysi
liquid
chromatographi
tandem
massspectrometri
lcmsm
also
call
ra
fingerprint
howev
ang
ii
level
significantli
chang
age
apelin
ko
mice
figur
b
though
trend
decreas
ang
ii
ratio
figur
thu
set
directli
examin
effect
ang
ii
signal
apelin
ko
mice
treat
apelin
ko
mice
wild
type
wt
mice
ang
ii
vehicl
week
use
osmot
minipump
vehicletr
apelin
ko
mice
blood
pressur
slightli
significantli
decreas
compar
wt
mice
figur
mice
continu
inject
ang
ii
week
wt
apelin
ko
mice
show
elev
blood
pressur
compar
manner
differ
hypertens
mice
figur
thu
endogen
apelin
littl
effect
ang
iiinduc
hypertens
sinc
apelin
ko
mice
show
reduc
express
heart
age
mice
mice
pressur
overload
stress
left
ventricl
examin
cardiac
express
ace
mrna
vehicletr
mice
express
heart
downregul
apelin
deplet
wherea
ace
express
alter
figur
b
consist
previou
result
hand
ang
ii
treatment
apelin
ko
mice
show
trend
decreas
express
heart
reach
statist
signific
figur
calcul
ratio
ace
express
apelin
ko
mice
show
increas
ratio
ace
express
compar
wt
mice
ang
ii
infus
well
vehicl
treatment
figur
thu
loss
apelin
enhanc
cardiac
effect
exogen
ang
ii
shift
balanc
ace
toward
ace
domin
state
cardiac
function
assess
echocardiographi
percent
fraction
shorten
fs
decreas
age
apelin
ko
mice
treat
vehicl
compar
agematch
wt
control
mice
receiv
vehicl
treatment
figur
b
tabl
consist
previou
result
week
continu
ang
ii
infus
wt
mice
show
nonsignific
reduct
fs
compar
vehicletr
wt
mice
figur
b
tabl
howev
ang
iitreat
apelin
ko
mice
show
mark
reduct
fs
compar
ang
iitreat
wt
mice
figur
b
tabl
echocardiographi
thick
interventricular
septum
iv
significantli
increas
ang
iiinfus
apelin
ko
mice
figur
suggest
ang
iimedi
cardiac
hypertrophi
enhanc
apelin
ko
mice
consist
apelin
ko
mice
ang
ii
infus
show
significantli
increas
heart
weight
bodi
weight
hwbw
ratio
compar
ang
iiinfus
wt
mice
figur
e
next
examin
cardiac
fibrosi
wellknown
outcom
enhanc
ang
ii
signal
heart
mild
fibrosi
interstiti
perivascular
area
observ
ang
iitreat
wt
mous
heart
figur
contrast
apelin
ko
mice
ang
ii
infus
exhibit
massiv
cardiac
fibrosi
figur
quantit
analysi
fibrot
area
heart
show
fibrot
area
ang
iitreat
apelin
ko
mous
heart
significantli
larger
wt
heart
ang
ii
treatment
figur
consist
mrna
express
fibrosisassoci
gene
collagen
transform
growthfactor
beta
latent
transform
growthfactor
betabind
protein
significantli
increas
ang
iitreat
apelin
ko
mice
compar
wt
mice
figur
wherea
vehicletr
apelin
ko
mice
gene
express
show
trend
decreas
reach
statist
signific
thu
ang
ii
augment
cardiac
dysfunct
hypertrophi
fibrosi
apelin
ko
mice
examin
whether
ang
ii
deplet
ace
inhibit
affect
cardiac
dysfunct
age
apelin
ko
mice
week
treatment
captopril
ace
inhibitor
acei
wt
apelin
ko
mice
subject
echocardiographi
decreas
percentag
fraction
shorten
fs
increas
endsystol
diamet
left
ventricl
lvesd
apelin
ko
mice
significantli
improv
acei
level
similar
wt
mice
figur
b
tabl
determin
whether
apelin
antagon
ang
ii
effect
vitro
treat
isol
primari
cardiomyocyt
ang
ii
peptid
ang
ii
treatment
induc
hypertroph
growth
mous
cardiomyocyt
affect
cell
size
figur
b
interestingli
combin
treatment
ang
ii
reduc
ang
iimedi
hypertrophi
cardiomyocyt
figur
b
consist
mrna
express
brain
natriuret
peptid
bnp
atrial
natriuret
factor
anf
upregul
ang
ii
treatment
wherea
significantli
decreas
elev
express
bnp
anf
ang
iitreat
cell
level
control
vehicletr
cardiomyocyt
figur
thu
apelin
antagon
ang
iimedi
hypertrophi
gene
express
cardiomyocyt
studi
demonstr
endogen
apelin
improv
exogen
ang
iiinduc
cardiac
dysfunct
patholog
remodel
well
antagon
endogen
ang
iimedi
impair
heart
contractil
age
mice
also
show
apelin
suppress
cellular
hypertrophi
profibrot
gene
express
vitro
cardiomyocyt
data
provid
direct
evid
endogen
apelin
crucial
antagon
ang
axi
cardiac
muscl
cell
endogen
apelin
antagon
ang
iiinduc
heart
patholog
upregul
express
interest
observ
ang
iistimul
elev
blood
pressur
increas
apelin
ko
mice
compar
wt
mice
sharp
contrast
mark
elev
blood
pressur
knockout
mice
treat
ang
ii
although
treatment
apelin
peptid
antagon
ang
iistimul
blood
pressur
elev
physiolog
effect
endogen
apelin
ra
seem
bias
heart
consist
initi
studi
apelin
ko
mice
first
identifi
phenotyp
cardiac
dysfunct
addit
ex
vivo
measur
cardiac
contractil
show
aceinhibitor
treatment
partli
rescu
impair
contractil
apelin
ko
mous
heart
unpublish
result
implic
intrins
cardiac
ra
activ
caus
heart
dysfunct
despit
numer
report
varieti
function
apelin
evid
suggest
heart
one
major
target
organ
endogen
apelin
patholog
respons
progress
heart
failur
involv
myocyt
hypertrophi
cardiac
fibrosi
crucial
mediat
ang
ii
signal
studi
show
apelin
inhibit
ang
iiinduc
cellular
hypertrophi
profibrot
gene
express
cardiomyocyt
vitro
result
explain
two
mechan
one
apelinmedi
downregul
ang
signal
level
receptor
intracellular
signal
apelinmedi
downmodul
ratio
subsequ
ang
ii
downregul
apelin
suppress
ang
iistimul
profibrot
signal
cardiomyocyt
downregul
express
postul
apelin
directli
inhibit
fibrogen
respons
fibroblast
apelin
inhibit
activ
cardiac
fibroblast
collagen
product
sphingosin
kinas
recent
tissuespecif
delet
apj
receptor
endotheli
cell
myocardi
cell
report
tac
transvers
aortic
constrict
pressur
overload
model
apj
delet
endotheli
cell
increas
cardiac
fibrosi
decreas
heart
contractil
wherea
cardiomyocytespecif
delet
apj
suppress
cardiac
hypertrophi
improv
heart
function
therefor
favor
effect
apelin
heart
like
mediat
complex
cellular
interact
signal
analysi
cell
type
heart
fibroblast
neuron
atrial
cell
would
warrant
precis
understand
apelin
signal
heart
current
find
establish
endogen
apelin
antagon
ang
axi
age
heart
apelin
recent
propos
antiag
peptid
mice
extend
healthi
life
span
prevent
sarcopenia
agingassoci
muscl
weak
current
drug
target
ra
ace
inhibitor
angiotensin
receptor
blocker
wide
use
clinic
ra
inhibit
per
se
inotrop
affect
thu
efficaci
cardiac
dysfunct
age
patient
would
rel
limit
develop
therapeut
strategi
stimul
apelinapj
signal
exert
posit
inotrop
protect
effect
heart
would
contribut
make
new
class
cardiovascular
medicin
age
societi
apelin
knockout
apelini
mice
gener
describ
backcross
mice
gener
mice
genotyp
pcr
southern
blot
maintain
anim
facil
akita
univers
graduat
school
medicin
anim
experi
conform
guid
care
use
laboratori
anim
publish
us
nation
institut
health
nih
public
revis
approv
experi
grant
ethic
review
board
akita
univers
march
ang
ii
treatment
wt
apelin
ko
mice
subcutan
infus
either
vehicl
ang
ii
sigmaaldrich
st
loui
mi
usa
mgkgday
week
osmot
minipump
alzet
model
alzet
corp
cupertino
ca
usa
aceinhibitor
treatment
wt
apelin
ko
male
mice
receiv
either
vehicl
captopril
mgl
drink
water
two
week
treatment
blood
pressur
measur
echocardiographi
perform
mice
sacrif
analysi
echocardiograph
measur
perform
previous
describ
briefli
mice
anesthet
isofluran
oxygen
echocardiographi
perform
use
fujifilm
tokyo
japan
equip
linear
transduc
fraction
shorten
fs
calcul
follow
fs
lvedd
lvesd
lvedd
mmode
imag
obtain
measur
wall
thick
chamber
dimens
use
leadingedg
convent
adapt
american
societi
echocardiographi
blood
pressur
measur
consciou
mice
programm
sphygmomanomet
softron
co
ltd
tokyo
japan
use
tail
cuff
method
day
daili
train
describ
previous
blood
sampl
collect
unit
heparin
optim
proteas
inhibitor
cocktail
plasma
kept
measur
metabolom
profil
angiotensin
peptid
conduct
attoqu
diagnost
gmbh
vienna
austria
use
technolog
describ
previous
evalu
activ
convert
enzym
present
plasma
equilibr
heparin
plasma
ex
vivo
incub
hour
obtain
steadyst
angiotensin
peptid
level
follow
addit
proteas
inhibitor
cocktail
ex
vivo
ra
fingerprint
sampl
subject
lcmsm
analysi
use
reversedphas
analyt
column
acquiti
water
co
milford
usa
oper
line
xevo
tq
tripl
quadrupol
mass
spectromet
water
describ
peptid
correspond
intern
standard
two
differ
mass
transit
measur
ten
angiotensin
peptid
metabolit
could
simultan
evalu
method
ang
ang
ang
ii
ang
iii
ang
iv
ang
ang
ang
ang
ang
heart
tissu
fix
formalin
embed
paraffin
five
section
prepar
stain
hematoxylin
eosin
masson
trichrom
rna
extract
use
trizol
reagent
invitrogen
carlsbad
ca
usa
cdna
synthes
use
primescript
rt
reagent
kit
takara
sequenc
forward
revers
primer
gene
studi
shown
supplementari
tabl
realtim
pcr
run
well
plate
use
sybr
premix
extaq
ii
takara
bio
shiga
japan
accord
instruct
manufactur
rel
gene
express
level
quantifi
use
thermal
cycler
dice
real
time
system
ii
softwar
takara
mous
cardiomyocyt
isol
prenat
mous
heart
wild
type
mice
describ
previous
briefli
prenat
mice
remov
pregnant
mice
euthan
cervic
disloc
prenat
mous
heart
harvest
rapidli
minc
mss
buffer
mm
hepe
mm
nacl
mm
glucos
mm
kcl
mm
ph
digest
collagenas
wako
osaka
japan
min
cardiomyocyt
collect
preplat
exclud
noncardiomyocyt
plate
gelatin
cultur
dish
plate
gibco
palo
alto
ca
usa
supplement
fetal
bovin
serum
equitech
bio
inc
kerrvil
tx
usa
data
present
mean
valu
sem
statist
signific
two
experiment
group
determin
use
student
twotail
ttest
comparison
paramet
among
group
analyz
oneway
anova
follow
turkey
posthoc
test
p
consid
signific
